Interestingly, we found patients with low PCDH17 expression harboring FLT3-ITD and NPM1 mutations (the two most common mutations in CN-AML) more often than those with PCDH17 high expression; GSEA analysis further confirmed this observation. The gene discussed is NPM1; the disease is acute myeloid leukemia.